Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
April 25, 2018 8:10 AM 8 min read

Investor Expectations to Drive Momentum within MicroStrategy, Marcus & Millichap, Gentex, Ultragenyx Pharmaceutical, Dave & Buster's Entertainment, and Glatfelter — Discovering Underlying Factors of Influence

by Globe Newswire
Follow

NEW YORK, April 25, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MicroStrategy Incorporated (NASDAQ:MSTR), Marcus & Millichap, Inc. (NYSE:MMI), Gentex Corporation (NASDAQ:GNTX), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Dave & Buster's Entertainment, Inc. (NASDAQ:PLAY), and Glatfelter (NYSE:GLT), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

MSTR DOWNLOAD: http://Fundamental-Markets.com/register/?so=MSTR
MMI DOWNLOAD: http://Fundamental-Markets.com/register/?so=MMI
GNTX DOWNLOAD: http://Fundamental-Markets.com/register/?so=GNTX
RARE DOWNLOAD: http://Fundamental-Markets.com/register/?so=RARE
PLAY DOWNLOAD: http://Fundamental-Markets.com/register/?so=PLAY
GLT DOWNLOAD: http://Fundamental-Markets.com/register/?so=GLT

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine MicroStrategy Incorporated (NASDAQ:MSTR), Marcus & Millichap, Inc. (NYSE:MMI), Gentex Corporation (NASDAQ:GNTX), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Dave & Buster's Entertainment, Inc. (NASDAQ:PLAY), and Glatfelter (NYSE:GLT) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

-----------------------------------------

MICROSTRATEGY INCORPORATED (MSTR) REPORT OVERVIEW

MicroStrategy's Recent Financial Performance

To read the full MicroStrategy Incorporated (MSTR) report, download it here: http://Fundamental-Markets.com/register/?so=MSTR

-----------------------------------------

MARCUS & MILLICHAP, INC. (MMI) REPORT OVERVIEW

Marcus & Millichap's Recent Financial Performance

To read the full Marcus & Millichap, Inc. (MMI) report, download it here: http://Fundamental-Markets.com/register/?so=MMI

-----------------------------------------

GENTEX CORPORATION (GNTX) REPORT OVERVIEW

Gentex's Recent Financial Performance

To read the full Gentex Corporation (GNTX) report, download it here: http://Fundamental-Markets.com/register/?so=GNTX

-----------------------------------------

ULTRAGENYX PHARMACEUTICAL INC. (RARE) REPORT OVERVIEW

Ultragenyx Pharmaceutical's Recent Financial Performance

To read the full Ultragenyx Pharmaceutical Inc. (RARE) report, download it here: http://Fundamental-Markets.com/register/?so=RARE

-----------------------------------------

DAVE & BUSTER'S ENTERTAINMENT, INC. (PLAY) REPORT OVERVIEW

Dave & Buster's Entertainment's Recent Financial Performance

To read the full Dave & Buster's Entertainment, Inc. (PLAY) report, download it here: http://Fundamental-Markets.com/register/?so=PLAY

-----------------------------------------

GLATFELTER (GLT) REPORT OVERVIEW

Glatfelter's Recent Financial Performance

To read the full Glatfelter (GLT) report, download it here: http://Fundamental-Markets.com/register/?so=GLT

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

REGISTERED MEMBER STATUS

LEGAL NOTICES

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Press Releases
GNTX Logo
GNTXGentex Corp
$23.97-%
Overview
MMI Logo
MMIMarcus & Millichap Inc
$25.760.43%
MSTR Logo
MSTRStrategy Inc
$131.00-0.04%
PLAY Logo
PLAYDave & Buster's Entertainment Inc
$15.701.88%
RARE Logo
RAREUltragenyx Pharmaceutical Inc
$22.72-%

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed April 23rd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

For the three months ended December 31st, 2017 vs December 31st, 2016, MicroStrategy reported revenue of $138.15MM vs $140.11MM (down 1.40%) and basic earnings per share -$2.30 vs $2.73. For the twelve months ended December 31st, 2017 vs December 31st, 2016, MicroStrategy reported revenue of $504.54MM vs $512.16MM (down 1.49%) and basic earnings per share $1.54 vs $7.96 (down 80.65%). MicroStrategy is expected to report earnings on April 26th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $1.28. The estimated EPS forecast for the next fiscal year is $3.32 and is expected to report on January 24th, 2019.

For the three months ended December 31st, 2017 vs December 31st, 2016, Marcus & Millichap reported revenue of $202.78MM vs $189.16MM (up 7.20%) and basic earnings per share $0.21 vs $0.44 (down 52.27%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Marcus & Millichap reported revenue of $719.70MM vs $717.45MM (up 0.31%) and basic earnings per share $1.32 vs $1.66 (down 20.48%). Marcus & Millichap is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.31. The estimated EPS forecast for the next fiscal year is $2.05 and is expected to report on March 14th, 2019.

For the three months ended December 31st, 2017 vs December 31st, 2016, Gentex reported revenue of $459.57MM vs $419.91MM (up 9.44%) and basic earnings per share $0.45 vs $0.31 (up 45.16%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Gentex reported revenue of $1,794.87MM vs $1,678.93MM (up 6.91%) and basic earnings per share $1.42 vs $1.21 (up 17.36%). Gentex is expected to report earnings on July 20th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.31. The estimated EPS forecast for the next fiscal year is $1.87 and is expected to report on January 25th, 2019.

For the three months ended December 31st, 2017 vs December 31st, 2016, Ultragenyx Pharmaceutical reported revenue of $2.41MM vs $0.01MM (up 48,180.00%) and basic earnings per share -$1.90 vs -$1.76. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ultragenyx Pharmaceutical reported revenue of $2.61MM vs $0.13MM (up 1,863.91%) and basic earnings per share -$7.12 vs -$6.21. Ultragenyx Pharmaceutical is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$1.63. The estimated EPS forecast for the next fiscal year is -$6.66 and is expected to report on February 19th, 2019.

For the three months ended January 31st, 2018 vs January 31st, 2017, Dave & Buster's Entertainment reported revenue of $304.91MM vs $270.18MM (up 12.85%) and basic earnings per share $0.88 vs $0.64 (up 37.50%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Dave & Buster's Entertainment reported revenue of $1,139.79MM vs $1,005.16MM (up 13.39%) and basic earnings per share $2.93 vs $2.16 (up 35.65%). Dave & Buster's Entertainment is expected to report earnings on June 5th, 2018. The report will be for the fiscal period ending April 30th, 2018. The reported EPS for the same quarter last year was $0.87. The estimated EPS forecast for the next fiscal year is $2.96 and is expected to report on April 2nd, 2019.

For the three months ended December 31st, 2017 vs December 31st, 2016, Glatfelter reported revenue of $401.70MM vs $392.99MM (up 2.21%) and basic earnings per share -$0.24 vs -$0.38. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Glatfelter reported revenue of $1,596.42MM vs $1,610.94MM (down 0.90%) and basic earnings per share $0.18 vs $0.49 (down 63.27%). Glatfelter is expected to report earnings on May 1st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.39. The estimated EPS forecast for the next fiscal year is $1.59 and is expected to report on February 5th, 2019.

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

GNTX Logo
GNTXGentex Corp
$23.97-%
Overview
MMI Logo
MMIMarcus & Millichap Inc
$25.760.43%
MSTR Logo
MSTRStrategy Inc
$131.00-0.04%
PLAY Logo
PLAYDave & Buster's Entertainment Inc
$15.701.88%
RARE Logo
RAREUltragenyx Pharmaceutical Inc
$22.72-%
Comments
Loading...